Tag Archives: Elemer Piros

Cantor Fitzgerald Reiterates Their Buy Rating on Arrowhead Research (ARWR)

In a report released today, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on Arrowhead Research (NASDAQ: ARWR), with a price target of $24. The company’s shares opened today at $13.87. Piros observed: “: We are reiterating our Overweight

Cantor Fitzgerald Believes Krystal Biotech Inc (NASDAQ: KRYS) Won’t Stop Here

In a report released today, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on Krystal Biotech Inc (NASDAQ: KRYS), with a price target of $35. The company’s shares opened today at $20.33, close to its 52-week high of $21.90.

Cantor Fitzgerald Thinks PolarityTE Inc’s Stock is Going to Recover

In a report released today, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on PolarityTE Inc (NASDAQ: PTE), with a price target of $65. The company’s shares closed on Friday at $14.16, close to its 52-week low of $14.

Arrowhead Research (ARWR) Receives a Buy from Cantor Fitzgerald

In a report released today, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on Arrowhead Research (NASDAQ: ARWR), with a price target of $24. The company’s shares opened today at $12.45. Piros observed: “: We are reiterating our Overweight

Cantor Fitzgerald Maintains a Buy Rating on Rigel (RIGL)

In a report released today, Elemer Piros from Cantor Fitzgerald maintained a Buy rating on Rigel (NASDAQ: RIGL), with a price target of $9. The company’s shares opened today at $3.15. Piros observed: “We believe Rigel is poised to achieved

Cantor Fitzgerald Thinks Spring Bank Pharmaceuticals Inc’s Stock is Going to Recover

Cantor Fitzgerald analyst Elemer Piros maintained a Buy rating on Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH) today and set a price target of $35. The company’s shares opened today at $11.79, close to its 52-week low of $10.63. Piros said: